Company Profiles

driven by the PitchBook Platform

Mirabilis

Mirabilis
2004 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Conv. Debt LATEST DEAL TYPE
$10.2M LATEST DEAL AMOUNT
$45.3M TOTAL AMOUNT RAISED
Description

Developer of a non-invasive therapeutic ultrasound platform designed to improve women's health. The company's Mirabilis system uses high-resolution ultrasound imaging to allow a physician to see inside the body to locate fibroids, and then focuses on high-intensity ultrasound in fibroid tissue to heat it and kill (ablate) the tissue, enabling them to treat diseases like uterine fibroids.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Diagnostic Equipment
Primary Office
18706 North Creek Parkway
Suite 104
Bothell, WA 98011
United States

+1 (425) 486-8230
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mirabilis’s full profile, request a free trial.

Mirabilis Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Convertible Debt 04-Aug-2016 $10.2M $45.3M Completed Generating Revenue
6. Secondary Transaction - Private 000.00 Completed Generating Revenue
5. Later Stage VC 01-Apr-2014 000 000.00 Completed Generating Revenue
4. Later Stage VC (Series A1) 13-Jun-2013 0000 000.00 000.00 Completed Generating Revenue
3. Early Stage VC 15-Aug-2012 000 000.00 Completed Generating Revenue
2. Convertible Debt 03-Feb-2011 $3.5M $15.2M Completed Generating Revenue
1. Early Stage VC (Series A) 29-Apr-2009 $11.7M $11.7M $14.2M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding request access »

Mirabilis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A1 00,000,000 00.000000 00.0 00 00 00 00 000
To view this company’s complete Cap Table request access »

Mirabilis Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Arboretum Ventures Venture Capital Minority 000 0000 000000 0
Charter Life Sciences Venture Capital Minority 000 0000 000000 0
Dow Venture Capital Corporate Venture Capital Minority 000 0000 000000 0
GSR Ventures Venture Capital Minority 000 0000 000000 0
Individual Investor Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Mirabilis Executive Team (2)

Name Title Board
Seat
Contact
Info
Jens Quistgaard Ph.D Chief Executive Officer, Board Member & President
Greg Darlington Vice President of Engineering

Mirabilis Board Members (5)

Name Representing Role Since Contact
Info
Fred Schwarzer Mirabilis Board Member 000 0000
Kevin Fong GSR Ventures Board Member 000 0000
Nelson Teng Ph.D Charter Life Sciences Board Member 000 0000
Roger Stern Mirabilis Board Member 000 0000

1 Former Board Members

You’re viewing 4 of 5 board members. Get the full list »